Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Core EBITDA Margin

    Back to All Ratios
PIRAMAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 8.4913.3512.427.7513.00

What is the latest Core EBITDA Margin ratio of PIRAMAL PHARMA ?

The latest Core EBITDA Margin ratio of PIRAMAL PHARMA is 8.49 based on Mar2026 Consolidated results.
Year Core EBITDA Margin
Mar20268.49
Mar202513.35
Mar202412.42
Mar20237.75
Mar202213.00

How is Core EBITDA Margin of PIRAMAL PHARMA Trending?

Years Core EBITDA Margin % Change
Mar2026 8.49
-36.40
Mar2025 13.35
7.49
Mar2024 12.42
60.26
Mar2023 7.75
-40.38
Mar2022 13 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Core EBITDA Margin ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹27,877.4 Cr 5.2% 21.8% 5.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -0.1% 0.5% 14% Stock Analytics
DIVIS LABORATORIES ₹218,972.0 Cr -0.9% 21.1% 25.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,358.0 Cr -1.3% 1.1% 32.7% Stock Analytics
CIPLA ₹118,916.0 Cr 0.2% 2.1% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,824.0 Cr 0.2% -7.7% -7.5% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

5.2%

21.8%

5.7%

SENSEX

0.5%

2.6%

-3.7%


You may also like the below Video Courses